Dexmedetomidine is an α2-adrenoceptor agonist with sedative, analgesic and anxiolytic effects which is more selective than clonidine. There is increasing use of this agent in the paediatric population. Dexmedetomidine has been used for various clinical procedures, including as part of an intraoperative anaesthetic technique for cardiac surgery, sedation during mechanical ventilation and for noninvasive procedures [1] [2] [3] . Recently, it has been reported that dexmedetomidine was successful in the prevention of emergence agitation (EA) following general anaesthesia in children in doses ranging from 0.3 to 1 µg.kg -1 as a bolus or 0.2 µg.kg -1 h -1 as an infusion [4] [5] [6] [7] .
Because not enough paediatric dexmedetomidine studies have been done, the indications for the use of dexmedetomidine in children are uncertain 8 .
Fentanyl is a short-acting opioid analgesic that has sedative effects. It is widely used in the practice of paediatric anaesthesia and paediatric perioperative medicine. Fentanyl (1 to 2 µg.kg -1 intranasally or 2.5 µg.kg -1 intravenously) reduces the incidence of EA in children who have received sevoflurane or desflurane 9, 10 .
The present study was designed to evaluate the effects of fentanyl and dexmedetomidine on emergence characteristics of children anaesthetised with sevoflurane.
MATERIALS AND METHODS
After obtaining approval of the ethics committee and informed parental consent, 90 ASA physical status I children, aged two to seven years, undergoing adenoidectomy with or without bilateral myringotomy and insertion of tubes were studied. Patients with a history of sleep apnoea, developmental delay or psychological disorders were not included in the study. All children received 
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This randomised controlled study evaluated the effects of fentanyl and dexmedetomidine on emergence characteristics of children having adenoidectomy and anaesthetised with sevoflurane.
Ninety children, two to seven years of age and ASA physical status I, were studied. Children were randomly assigned to one of three groups of 30 children, with the study intervention injection given intravenously after intubation. Children in Group F received fentanyl 2.5 µg.kg -1 , children in Group D received dexmedetomidine 0.5 µg.kg -1 and children in Group C received saline solution. Anaesthesia was induced with 50% N 2 O and 8% sevoflurane in O 2 by mask and atracurium 0.6 mg.kg -1 was administered for tracheal intubation. All children received paracetamol 40 mg/kg rectally one hour preoperatively and dexamethasone 0.5 mg.kg -1 intravenously.
The time to extubation was shorter in Group D than Group F. The eye-opening time was longer in Group F (16.1±5.3 minutes) than in Groups C (12.0±4.2 minutes) and D (12.7±3.2 minutes). The proportion of painfree children in early recovery was significantly higher in Groups D (47%) and F (43%) than Group C (13%) (P <0.05). The proportion of children with agitation scores >3 was lower in Groups D 17% (5/30) and F 13% (4/30) than in Group C 47% (14/30) (P <0.05). Fentanyl 2.5 µg.kg -1 and dexmedetomidine 0.5 µg.kg -1 had similar haemodynamic effects and emergence characteristics. Fentanyl has been safely used in children for many years. Further studies of dexmedetomidine safety and its interaction with other anaesthetic agents are required before recommending its routine use during general anaesthesia in children.
key Words: emergence characteristics, sevoflurane, dexmedetomidine, fentanyl paracetamol 40 mg.kg -1 rectally approximately 60 minutes before induction of anaesthesia. Parents were allowed to be present during induction and the presence of the children's agitation or combative behaviour of at that time was recorded.
Standard monitoring included electrocardiogram, blood pressure cuff, pulse oximeter, temperature and end-tidal gas measurements. Anaesthesia was induced with 50% N 2 O and 8% sevoflurane in O 2 by mask. After an intraveous catheter placement, atracurium 0.6 mg.kg -1 for tracheal intubation and dexamethasone 0.5 mg.kg -1 (maximum dose 12 mg) for pain and vomiting were administered. After induction, children were randomly assigned to one of two treatment groups or to the control group using a computer-generated random number table. Children in group F received fentanyl 2.5 µg.kg -1 whereas children in group D received dexmedetomidine 0.5 µg.kg -1 after tracheal intubation. Dexmedetomidine and fentanyl were prepared by a team member not involved in data recording (ZB). The doses of the study drugs were diluted in 10 ml saline and given over 10 minutes. Children in group C received only saline solution in the same manner. The syringes were labelled with the child's study number.
Anaesthesia was maintained with sevoflurane 1.5 to 2.5% (inspired concentration) in 70% N 2 O/O 2 in all patients. The anaesthetic gas concentrations were adjusted to maintain adequate anaesthesia and stable haemodynamics. Ventilation was controlled to maintain an end-tidal CO 2 of 35 to 40 mmHg. At the completion of surgery, the anaesthetics were discontinued and the stomach was suctioned. Any residual neuromuscular blockade, as determined by train-of-four monitoring, was reversed with 50 µg.kg -1 neostigmine and 20 µg.kg -1 atropine, and the children were allowed to breathe spontaneously. After return of sufficient spontaneous ventilation (V T >5 ml.kg -1 , respiratory rate >12 breath.min -1 ) and gag reflex, the tracheal tube was removed and the patients were transferred to the recovery room. The times from discontinuation of anaesthetics (time= 0 minutes) to tracheal extubation and to eye-opening in response to verbal stimuli were recorded.
In the recovery room, all children received humidified O 2 by facemask for 10 minutes and had at least one parent in attendance. Emergence agitation was assessed using a 1 to 5 point scale ( Table 1) 11 . The Objective Pain Scale (OPS) was used to assess pain 12 . Severe pain (score ≥4) with or without severe agitation (score ≥4) was treated with intravenous fentanyl (1 µg.kg -1 ). Agitation without pain was treated with intravenous midazolam 0.1 mg.kg -1 . All measurements and observations were recorded by the blinded anaesthesists (FE, SD).
Children were discharged from the recovery room when they satisfied the following criteria: fully awake, stable vital signs for at least 30 minutes, patent airway without manipulation, oxygen saturation >95% on room air and no sign of pain or vomiting. All children stayed for at least two hours in the recovery room. Children were visited 24 hours after surgery to assess the incidence of agitation, pain and vomiting.
According to a power analysis, a sample size of 30 patients per group would have an 80% power to detect a reduction in the incidence of agitation from 50 to 20% at a significance level of 5%. Statistical analyses of the study were performed using SPSS for Windows, version 10.0 (SPSS Inc., Chicago, IL, USA). Data were compared among the groups using one-way analysis of variance followed by a post-hoc testing Bonferroni or kruskal-Wallis test as appropiate. Haemodynamic variables within group were analysed using repeated-measures analysis of variance and then Bonferroni correction. The incidence of side-effects were analysed by the chi-square test. A P value of <0.05 was considered to be statistically significant.
RESULTS
The groups were similar in respect to demographic characteristics, duration of surgery and anaesthesia ( Table 2 ). Mean arterial pressure (MAP) and heart rate (HR) were not different between groups F and D. In group C, MAP and HR were significantly higher than Group F, one minute after the start of surgery (MAP 86.2±8.2 and 79.8±9.1; HR 118.6±11.5 and 108.7±10.5, respectively) and extubation (MAP 94.9±8.8 and 88.6±9.8; HR 123.7±9.7 and 114.8±11.4, respectively) (P <0.05). HR was higher in group C than group D (116.2±9.9) one minute after extubation (P <0.05). No child experienced hypotension or bradycardia. The time to extubation in groups F and D (11.2±3.9 and 8.5±3.6 minutes, respectively) was not significantly different from that in Group C (9.5±3.8 minutes). However, it was significantly shorter in group D than group F (P <0.05). The eye-opening time was significantly longer in Group F (16.1±5.3 minutes) than those in group C (12.0±4.2 minutes) and group D (12.7±3.2 minutes) (P <0.05) ( Table 3) .
The incidence of EA (score ≥4) was 13% (4/30) in group F, 17% (5/30) in group D and 47% (14/30) in group C (P <0.05) ( Table 4 ). The incidence of severe pain (score ≥4) was not different between the groups. However, the number of painfree children was significantly higher in Groups D and F than group C (P <0.05) ( Table 4 ). The number of children who vomited during the recovery period was one each in groups C and D and three in group F. In the recovery room, fentanyl was given to 13 children in group C, four in group F and five in Group D, while midazolam was given to nine children in group C, two in group F and two in Group D. There were no major complications such as oxygen desaturation (SpO 2 <95%), laryngospasm or bronchospasm observed in any patient at any time during the study period.
DISCUSSION
Fentanyl is very commonly used in children and its pharmacology has been extensively studied. Fentanyl does not lead to significant cardiovascular depression when given in a small dose 13, 14 to healthy children. In the present study, MAP was lower than the baseline upon fentanyl administration. When compared with the control group, fentanyl attenuated the haemodynamic response to the onset of surgery and extubation. Dexmedetomidine decreases blood pressure and HR in a dose-dependent manner 2, 15 . There are limited data regarding the haemodynamic effects when dexmedetomidine is administered together with inhalational anaesthetic agents in children. Deutsch et al 16 reported that administration of dexmedetomidine 0.5 µg.kg -1 over five minutes decreased the blood pressure and HR during general anaesthesia with either sevoflurane or desflurane in children, and the decrease in HR was more pronounced with sevoflurane. In the present study, the administration of dexmedetomidine 0.5 µg.kg -1 over 10 minutes decreased the MAP compared with the baseline value. Dexmedetomidine had no significant haemodynamic effects when compared to control and fentanyl groups.
In the present study, the subjects were studied in a population at high risk of agitation, i.e. preschool children undergoing sevoflurane anaesthesia for ear, nose and throat surgery. Since awakening in an unfamiliar environment may provoke EA, we allowed parental presence in the recovery room. In our study, the incidence of EA was 47% (14/30) in the control group and similarly lower in the fentanyl 13% (4/30) and dexmedetomidine 17% (5/30) groups in children anaesthetised with sevoflurane. Cohen et al 17 have reported that the effective dose of fentanyl for reducing EA without delaying emergence was 2.5 µg.kg -1 . Consistent with our results, they found that the incidence of severe agitation was 18% in children who received fentanyl 2.5 µg.kg -1 intravenously with sevoflurane anaesthesia for adenoidectomy 10 .
Dexmedetomidine has been also shown to be effective in attenuating the incidence of EA after sevoflurane anaesthesia. After the induction of anaesthesia for lower abdominal or genital surgery with caudal block, the administration of dexmedetomidine 0.3 µg.kg -1 decreased the EA from 37 to 10% 4 . Shukry et al 7 studied continuous infusions of dexmedetomidine (0.2 µg.kg -1 h -1 ) during surgery and determined that the incidence of EA decreased from 61 to 26%. In these studies, the time to extubation and eye-opening were not different with dexmedetomidine versus placebo.
In accordance with the present study, guler et al 5 demonstrated that dexmedetomidine 0.5 µg.kg -1 five minutes before the end of surgery reduced the incidence of EA from 57 to 17%. However, they reported that time to extubation and emergence were longer with dexmedetomidine versus placebo. In contrast with their study, we administered dexmedetomidine after tracheal intubation and the time to extubation and eye-opening was similar to that in the control group.
Pain has been one of the confounding factors for emergence agitation. Pain after adenoidectomy is typically described as moderate 10 . In Turkey, diclofenac and ibuprofen are the only nonsteroidal anti-inflammatory drugs which are licensed for use in children. Nonsteroidal anti-inflammatory drugs have been associated with increased intraoperative bleeding 18 . Because of the low incidence of adverse effects, paracetamol is the most widely used analgesic drug for mild to moderate pain in children. Corpela et al reported that rectal paracetamol 40 to 60 mg.kg -1 effectively reduced the incidence of pain after adenoidectomy in children 19 . In addition, Viitanen et al 20 demonstrated that paracetamol had equal analgesic efficacy to ibuprofen after adenoidectomy. Therefore, we administered paracetamol 40 mg.kg -1 rectally as our baseline analgesia for all groups.
A meta-analysis by Afman et al recommended intravenous dexamethasone during routine tonsillectomy or adenoidectomy to reduce postoperative emesis and pain 21 . In several studies, the doses of dexamethasone for pain after tonsillectomy or adenotonsillectomy in children ranged from 0.4 to 1 mg.kg -1 with maximum doses from 8 mg to 50 mg 22, 23 . Elhakim et al 24 reported that prophylactic intraoperative intraveous dexamethasone 0.5 mg.kg -1 decreases the incidence of postoperative vomiting and reduced pain scores in children during the first 24 hours after tonsillectomy performed with a standardised anaesthetic technique. Because complications from corticosteroid therapy, such as increased risk of infection, delayed wound healing and adrenal suppression are usually related to its long-term use, single-dose dexamethasone is considered safe. Therefore, all children received dexamethasone 0.5 mg.kg -1 intravenously in our study. Distinguishing the diagnosis of pain at emergence from emergence delirium may be difficult as the behaviours may appear similar, at least intitially, and similar pharmacological treatment options may be indicated with some urgency before the clinical distinction is made. Some studies have focussed on recovery from anaesthesia for procedures where pain in recovery is unlikely, such as medical imaging or procedures where the pain is expected to be eliminated by local anaesthesia. In the present study, if a child failed to recognise his or her parent during the agitated postoperative state, this situation was defined as EA. Although the incidence of severe pain was not different among groups, the percentage of pain-free children was higher in the dexmedetomidine and fentanyl groups than control group. Thus, the limitation of this study is the inability to completely eliminate the effects of pain on the incidence and diagnosis of EA in the control group. On the other hand, these findings suggested that dexmedetomidine provides considerable analgesia similar to fentanyl after adenoidectomy. In accordance with our results, Olutoye et al 25 reported that postoperative analgesic requirements of children did not differ between a single intraoperative dose of dexmedetomidine 0.5 µg.kg -1 or morphine 50 µg.kg -1 after adenotonsillectomy.
Similar to all studies regarding EA, the present study is limited by the lack of a widely used and validated tool for measuring agitation. Recently, Sikich and Lerman 26 developed a paediatric anaesthesia emergence delirium scale incorporating cognitive-related assessment items in addition to agitation behaviours and proved its reliability and validity. Since they did not provide a validated threshold value in the paediatric anaesthesia emergence delirium scale to indicate EA, the incidence of EA can not be estimated. Therefore we used a simple graded scale that is very similar to those used by other investigators.
In the present study, the doses of fentanyl and dexmedetomidine used may not be equipotent. The effective dose of fentanyl in reducing EA has been determined 17 . However, there is no study related to the optimal dose of dexmedetomidine that would decrease EA. Upon review of the previous studies, we noted that dexmedetomidine 0.5 or 1 µg.kg -1 as a bolus dose reduced the incidence of EA by similar amounts (from 57 to 17%, from 47.8 to 4.8%, respectively) 5,6 . Therefore we administered dexmedetomidine in a dose of 0.5 µg.kg -1 .
Dexmedetomidine possibly exerts its effects on EA through its analgesic and sedative properties, like fentanyl. Unlike fentanyl, it should be prepared, solubilised and diluted for administration via a syringe pump. Furthermore, with an elimination half-time of 1.8 hours in children 27 , dexmedetomidine is not ideal for ambulatory surgery 28 . With these properties, dexmedetomidine is not likely to offer any advantage over fentanyl.
In conclusion, fentanyl 2.5 µg.kg -1 and dexmedetomidine 0.5 µg.kg -1 had similar haemodynamic effects and emergence characteristics in children having adenoidectomy. In terms of significant haemodynamic adverse effects in children without cardiovascular impairment, fentanyl has been used safely for many years. Although dexmedetomidine was well tolerated in this study, more data regarding the safety of dexmedetomidine and its interaction with other anaesthetic agents is required, before suggesting that the responses to the drug are sufficiently minimal enough to recommend its use during general anaesthesia in children.
